Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,212
Closed -$414K 1827
2025
Q2
$414K Buy
+4,212
New +$399K 0.05% 403
2023
Q2
Sell
-332
Closed -$24.4K 1553
2023
Q1
$24.4K Buy
+332
New +$28.7K 0.01% 1374
2022
Q4
Sell
-284
Closed -$27K 1561
2022
Q3
$27K Buy
+284
New +$33.9K 0.01% 1209
2022
Q1
Sell
-36
Closed -$6K 1782
2021
Q4
$6K Buy
36
+10
+38% +$1.61K ﹤0.01% 1703
2021
Q3
$4K Sell
26
-15
-37% -$3.12K ﹤0.01% 1105
2021
Q2
$10K Buy
41
+25
+156% +$6.56K 0.01% 1010
2021
Q1
$4K Buy
+16
New +$4.51K 0.01% 445

Other funds holding AMED

State of Wyoming's AMED Position: Q3 2025 in Review

State of Wyoming sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,212 shares — an estimated $414K sold.

State of Wyoming first reported a position in AMED in Q1 2021 and held it in 7 quarters. The position peaked at $414K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • State of Wyoming reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • State of Wyoming sold 4,212 Amedisys shares in Q3 2025, an estimated $414K.
  • State of Wyoming first reported a position in Amedisys in Q1 2021 and held it in 7 quarters.
  • State of Wyoming's Amedisys position peaked at $414K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on State of Wyoming's 13F filing for Q3 2025, filed 4 Nov 2025.